Lumea and P4 Diagnostix partnership press release LEHI, UT, October 13, 2022—Lumea Inc, a global leader in integrated digital pathology solutions, is pleased to announce a strategic partnership with P4…
Read More
AZoRobotics recently featured the new Lumea and Tempus digital pathology and artificial intelligence collaboration. More advancements are happening between pathology and artificial intelligence every year. This one is particularly exciting because…
Lumea, a leader in digital pathology solutions, has chosen Tempus, a leader in artificial intelligence and precision medicine, to create AI-enabled solutions LEHI, UTAH, UNITED STATES, August 4, 2022 — Lumea…
An ancillary or molecular test is a medical test for a patient that is not a part of the original study design. There are a wide variety of ancillary tests…
LEHI, UTAH, USA — June 1, 2022 — Lumea Inc, a global leader in integrated digital pathology solutions, is pleased to announce the first-of-its-kind Digital Diagnostic Summit in Park City,…
Lumea Inc., a global leader in integrated digital pathology solutions, is pleased to announce the first-of-its-kind Digital Diagnostic Summit in Park City, Utah. Today, Lumea announces the presenters for the…
